Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.


Results 1-4 of 4 (Search time: 0.002 seconds).
  • previous
  • 1
  • next
Item hits:
PreviewIssue DateTitleAuthor(s)
2015Quantifying change in pulmonary function as a prognostic marker in systemic sclerosis-related interstitial lung diseaseMoore, O.A.; Proudman, S.M.; Goh, N.; Corte, T.J.; Rouse, H.; Hennessy, O.; Morrisroe, K.; Thakkar, V.; Sahhar, J.; Roddy, J.; Youssef, P.; Gabbay, E.; Nash, P.; Zochling, J.; Stevens, W.; Nikpour, M.; 2013 ACR/ARHP Annual Meeting (25 Oct 2013 - 30 Oct 2013 : San Diego, CA)
2019Development and validation of the Scleroderma Clinical Trials Consortium Damage Index (SCTC-DI): A novel instrument to quantify organ damage in systemic sclerosisFerdowsi, N.; Huq, M.; Stevens, W.; Hudson, M.; Wang, M.; Tay, T.; Burchell, J.L.; Mancuso, S.; Rabusa, C.; Sundararajan, V.; Prior, D.; Proudman, S.M.; Baron, M.; Nikpour, M.
2021Anti-Ro52/TRIM21 is independently associated with pulmonary arterial hypertension and mortality in a cohort of systemic sclerosis patientsLee, A.; Patterson, K.A.; Tan, D.J.; Wilson, M.E.; Proudman, S.M.; Stevens, W.; Nikpour, M.; Sahhar, J.; Ngian, G.-S.; Roddy, J.; Roberts-Thomson, P.J.; Walker, J.G.
2016The role of asymmetric dimethylarginine alone and in combination with N-terminal pro-B-type natriuretic peptide as a screening biomarker for systemic sclerosis-related pulmonary arterial hypertension: a case control studyThakkar, V.; Stevens, W.; Prior, D.; Rabusa, C.; Sahhar, J.; G Walker, J.; Roddy, J.; Lester, S.; Rischmueller, M.; Zochling, J.; Nash, P.; Gabbay, E.; Youssef, P.; Proudman, S.M.; Nikpour, M.